Large-scale testing (Phase 3)Study completedNCT00216593
What this trial is testing
Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
Who this might be right for
DementiaAlzheimer Disease
Janssen Pharmaceutica N.V., Belgium 415